FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

OptumHealth Recalls Nimbus Infusion Pumps

OptumHealth Care Solutions recalls (Class 1) its Nimbus II Plus infusion pumps due to multiple potential failure modes that may include battery failur...

latest-news-card-1
FDA General

Office of Regulatory Affairs, Other Changes Approved

FDA says an agency reorganization changing the operation of the Office of Regulatory Affairs is scheduled to take effect 10/1.

latest-news-card-1
Human Drugs

Uses of and Issues with AI in Trial Design

CDER Office of Medical Policy director Khair ElZarrad uses a podcast to discuss the benefits and challenges of using artificial intelligence in drug d...

latest-news-card-1
Human Drugs

CDER Lists 10 Pharmaceutical Quality Functions

CDER posts a list of 10 things it says people should know about the Centers pharmaceutical quality function.

latest-news-card-1
Medical Devices

Medline Recalls Endotracheal Tube

Medline Industries recalls (Class 1) its Medline Sub-G Endotracheal Tube with Subglottic Suctioning after complaints were received about the devices i...

latest-news-card-1
Medical Devices

Disclose Locked Hearing Aids: Members of Congress

A bipartisan group of 11 Senate and House members asks FDA to require hearing aid labeling to disclose if the device uses proprietary software that af...

latest-news-card-1
Human Drugs

ICH M12 Drug Interaction Guideline Out

The International Council on Harmonization publishes the M12 final guideline on drug interactions and an accompanying question-and-answer document.

latest-news-card-1
Federal Register

Anzures-Camarena Debarred Over Counterfeits

Federal Register notice: FDA issues an order permanently debarring Maria Anzures-Camarena from providing services related to an approved or pending dr...

latest-news-card-1
Human Drugs

3 No-Longer-Marketed NDAs Withdrawn

Federal Register notice: FDA withdraws three NDAs from multiple applicants after they notified the agency that the products were no longer marketed....

latest-news-card-1
Human Drugs

FDA Oks Amgens Bkemv as Soliris Biosimilar

FDA approves Amgens Bkemv as an interchangeable biosimilar for Alexions Soliris, indicated to treat two rare diseases.